Sleep Number (SNBR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
24 Mar, 2026Executive summary
Leadership transition in April 2025 focused on operational streamlining, cost reduction of $136 million compared to 2024, and extension of the bank agreement through 2027.
Strategic plan “Sleep Number Shifts” targets product simplification, marketing transformation, and expanded distribution to drive growth.
Board and management are committed to enhanced governance, with several proposals resubmitted for shareholder approval after narrowly missing required votes in 2025.
Forward-looking statements highlight ongoing risks and uncertainties, including industry recession and macroeconomic challenges.
Voting matters and shareholder proposals
Seven proposals up for vote: election of three directors, declassification of the board, elimination of supermajority voting for directors and certain transactions, auditor ratification, advisory say-on-pay, and amendment to the 2020 Equity Incentive Plan to add 750,000 shares.
Board recommends voting “For” all proposals, emphasizing governance modernization and alignment with shareholder interests.
Proposals to declassify the board and eliminate supermajority requirements require two-thirds of outstanding shares for approval.
Board of directors and corporate governance
Board reduced from 12 to 7 members since 2025, with significant refreshment and new leadership.
Three director nominees (Eyler, Howard, Mendez) recommended for election; if declassification passes, all directors will stand for annual election starting 2027.
Board diversity in gender, race/ethnicity, age, and tenure is highlighted.
Board committees (Audit, Compensation, CGNC) are fully independent and meet regularly; leadership structure separates Chair and CEO roles.
Shareholder engagement is ongoing, with outreach to holders of over 60% of shares between Jan 2025 and Mar 2026.
Latest events from Sleep Number
- Turnaround strategy and cost reductions set the stage for growth and free cash flow in 2026.SNBR
Investor presentation12 Mar 2026 - Cost savings and new products drive turnaround, setting up double-digit EBITDA growth for 2026.SNBR
Q4 202512 Mar 2026 - Gross margin and cost improvements offset sales declines, supporting full-year EBITDA guidance.SNBR
Q2 20242 Feb 2026 - Gross margin hit a three-year high as cost cuts offset a 10% sales decline in Q3.SNBR
Q3 202417 Jan 2026 - Major transformation underway with cost cuts, new products, and a focus on value-driven growth.SNBR
28th Annual ICR Conference 202613 Jan 2026 - Transformation plan targets growth, efficiency, and strong free cash flow in 2026.SNBR
Investor presentation13 Jan 2026 - Gross margin gains and cost cuts drove Q4 EBITDA up 43% despite double-digit sales declines.SNBR
Q4 202425 Dec 2025 - Q1 2025 sales dropped 16% with a $8.6–$9M net loss, but gross margin rose to 61.2%.SNBR
Q1 202523 Dec 2025 - Board proposes governance reforms, new CEO, and equity plan changes amid industry headwinds.SNBR
Proxy Filing1 Dec 2025